Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
0.2930
-0.0240 (-7.57%)
At close: May 16, 2025, 4:00 PM
0.2999
+0.0069 (2.35%)
After-hours: May 16, 2025, 7:31 PM EDT
Bolt Biotherapeutics Market Cap
Bolt Biotherapeutics has a market cap or net worth of $11.23 million as of May 16, 2025. Its market cap has decreased by -73.34% in one year.
Market Cap
11.23M
Enterprise Value
-2.90M
1-Year Change
-73.34%
Ranking
Category
Stock Price
$0.29
Market Cap Chart
Since the IPO on February 5, 2021, Bolt Biotherapeutics's market cap has decreased from $690.43M to $11.23M, a decrease of -98.37%. That is a compound annual growth rate of -61.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2025 | 12.15M | -40.66% |
| Dec 31, 2024 | 20.48M | -51.84% |
| Dec 29, 2023 | 42.52M | -13.15% |
| Dec 30, 2022 | 48.96M | -73.20% |
| Dec 31, 2021 | 182.69M | -73.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 676.55B |
| Johnson & Johnson | 364.38B |
| AbbVie | 323.20B |
| Novo Nordisk | 282.81B |
| UnitedHealth Group | 262.25B |
| Abbott Laboratories | 234.90B |
| Novartis AG | 211.47B |
| AstraZeneca | 208.86B |